Type 2 diabetes and risk of cognitive impairment and dementia (Q36926037)

17 August 2017

1 reference

title

Type 2 diabetes and risk of cognitive impairment and dementia (English)

1 reference

17 August 2017

0 references

0 references

cognitive dysfunction

1 reference

1

Rachel A Whitmer

1 reference

17 August 2017

1 September 2007

1 reference

Current Neurology and Neuroscience Reports

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

5

1 reference

17 August 2017

373-380

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-007-0058-7

17 August 2017

0 references

cites work

Insulin increases CSF Abeta42 levels in normal older adults

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

The influence of smoking on the risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Essential hypertension and cognitive function. The role of hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Inflammatory markers and cognition in well-functioning African-American and white elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-007-0058-7

Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment

21 January 2018

1 reference

12 December 2020

Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study

1 reference

12 December 2020

Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging

1 reference

12 December 2020

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

1 reference

12 December 2020

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

1 reference

12 December 2020

Cerebral microvascular pathology in aging and Alzheimer's disease

1 reference

12 December 2020

15-year longitudinal study of blood pressure and dementia

1 reference

12 December 2020

Glucose regulation and brain aging

1 reference

12 December 2020

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Advanced protein glycosylation in diabetes and aging

1 reference

12 December 2020

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

1 reference

12 December 2020

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

12 December 2020

Role of insulin and insulin receptor in learning and memory

1 reference

12 December 2020

Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old.

1 reference

12 December 2020

Cerebral function in diabetes mellitus.

1 reference

12 December 2020

New classification and diagnostic criteria for diabetes mellitus

1 reference

12 December 2020

Epidemiology of Alzheimer's Disease

1 reference

12 December 2020

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

1 reference

12 December 2020

Glucose intolerance, cognitive impairment and Alzheimer's disease.

1 reference

12 December 2020

Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression.

1 reference

12 December 2020

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

1 reference

12 December 2020

Effect of glucose and peripheral glucose regulation on memory in the elderly.

1 reference

12 December 2020

Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study

1 reference

12 December 2020

Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women.

1 reference

12 December 2020

Are antihypertensive agents protective against dementia? A review of clinical and preclinical data

1 reference

12 December 2020

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats

1 reference

12 December 2020

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

1 reference

12 December 2020

Negative consequences of glycation.

1 reference

12 December 2020

Morphological changes of microvessels in the brain with Alzheimer's disease

1 reference

12 December 2020

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

1 reference

12 December 2020

Insulin and neurodegenerative disease: shared and specific mechanisms

1 reference

12 December 2020

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

1 reference

12 December 2020

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

1 reference

12 December 2020

Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study.

1 reference

12 December 2020

The burden of type 2 diabetes: are we doing enough?

1 reference

12 December 2020

Can disturbed brain microcirculation cause Alzheimer's disease?

1 reference

12 December 2020

Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects

1 reference

12 December 2020

The metabolic syndrome, inflammation, and risk of cognitive decline

1 reference

12 December 2020

Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?

1 reference

12 December 2020

Advanced glycation end-products: a review

1 reference

12 December 2020

Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress

1 reference

12 December 2020

Insulin and the insulin receptor in experimental models of learning and memory.

1 reference

12 December 2020

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

1 reference

12 December 2020

Cognition and synaptic plasticity in diabetes mellitus

1 reference

12 December 2020

Glucocorticoid-induced impairment in declarative memory performance in adult humans.

1 reference

12 December 2020

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

12 December 2020

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

1 reference

12 December 2020

Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein

1 reference

12 December 2020

Diabetes--a common, growing, serious, costly, and potentially preventable public health problem.

1 reference

12 December 2020

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort

1 reference

12 December 2020

The risk of dementia among persons with diabetes mellitus: a population-based cohort study.

1 reference

12 December 2020

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men.

1 reference

12 December 2020

Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study

1 reference

12 December 2020

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

1 reference

12 December 2020

Vascular risks and incident dementia: results from a cohort study of the very old.

1 reference

12 December 2020

Insulin receptors and insulin action in the brain: review and clinical implications

1 reference

12 December 2020

Impact of diabetes on cognitive function among older Latinos: a population-based cohort study

1 reference

12 December 2020

Hippocampal neuronal apoptosis in type 1 diabetes

1 reference

12 December 2020

Cholesterol and pathological processes in Alzheimer's disease

1 reference

12 December 2020

Association of diabetes mellitus and dementia: the Rotterdam Study.

1 reference

12 December 2020

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

1 reference

12 December 2020

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

1 reference

12 December 2020

Vascular factors in cognitive impairment--where are we now?

1 reference

12 December 2020

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

1 reference

12 December 2020

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

12 December 2020

Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease

1 reference

12 December 2020

Dementia and its associations in type 2 diabetes mellitus: the Fremantle Diabetes Study.

1 reference

12 December 2020

The blood-brain barrier and cerebral microcirculation in Alzheimer disease

1 reference

12 December 2020

Type 2 diabetes mellitus, cognitive impairment and dementia.

1 reference

12 December 2020

Cognitive function and glycosylated hemoglobin in older patients with type II diabetes.

1 reference

12 December 2020

Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control

1 reference

12 December 2020

Central nervous system complications of diabetes mellitus--a perspective from the blood-brain barrier

1 reference

12 December 2020

Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats.

1 reference

12 December 2020

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

12 December 2020

Effect of glucose, glucose regulation, and word imagery value on human memory.

1 reference

12 December 2020

Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.

1 reference

12 December 2020

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

1 reference

12 December 2020

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.

1 reference

12 December 2020

Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study

1 reference

12 December 2020

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

12 December 2020

Improving influence of insulin on cognitive functions in humans

1 reference

12 December 2020

10.1007/S11910-007-0058-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17764626